Innovations and Challenges in Foot-and-Mouth Disease Vaccine Development: Bridging Traditional Methods with Emerging Technologies
Innovations and Challenges in Foot-and-Mouth Disease Vaccine Development: Bridging Traditional Methods with Emerging Technologies
Mostafa R. Zaher1,2*, Amir A. Shehata1, Azza M. El Amir2, Naglaa M. Hagag1, Reham H. Tammam3**
Figure 3:
Different types of RNA vaccines; UTR: untranslated regions; CSE: conserved sequence element; nsP: non-structural protein; RdRP: RNA-dependent RNA Polymerase.
Figure 1:
FMDV genomic structure showing the 5`UTR, P1, P2, P3 and 3`UTR segments.
Figure 2:
Types of FMDV vaccines.
